nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—DNMT1—Trans-sulfuration pathway—GOT1—liver cancer	0.0177	0.0912	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—NDRG1—liver cancer	0.0127	0.0657	CbGpPWpGaD
Decitabine—DNMT3A—embryo—liver cancer	0.01	0.338	CbGeAlD
Decitabine—DCK—Doxorubicin—Epirubicin—liver cancer	0.00988	0.519	CbGdCrCtD
Decitabine—DCK—Epirubicin—Doxorubicin—liver cancer	0.00914	0.481	CbGdCrCtD
Decitabine—DNMT3A—One Carbon Metabolism—MTHFR—liver cancer	0.00903	0.0467	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—HCFC1—liver cancer	0.00823	0.0425	CbGpPWpGaD
Decitabine—DNMT3A—Trans-sulfuration and one carbon metabolism—MTHFR—liver cancer	0.00812	0.0419	CbGpPWpGaD
Decitabine—DNMT1—One Carbon Metabolism—MTHFR—liver cancer	0.0061	0.0315	CbGpPWpGaD
Decitabine—DNMT1—embryo—liver cancer	0.00605	0.204	CbGeAlD
Decitabine—DNMT1—Trans-sulfuration and one carbon metabolism—MTHFR—liver cancer	0.00548	0.0283	CbGpPWpGaD
Decitabine—DNMT3A—DNA methylation—H2AFX—liver cancer	0.00527	0.0272	CbGpPWpGaD
Decitabine—DNMT3A—PRC2 methylates histones and DNA—H2AFX—liver cancer	0.00479	0.0247	CbGpPWpGaD
Decitabine—DNMT3A—liver—liver cancer	0.00463	0.156	CbGeAlD
Decitabine—DNMT3A—RMTs methylate histone arginines—H2AFX—liver cancer	0.00453	0.0234	CbGpPWpGaD
Decitabine—DCK—embryo—liver cancer	0.00418	0.141	CbGeAlD
Decitabine—DNMT1—Regulation of retinoblastoma protein—ABL1—liver cancer	0.0037	0.0191	CbGpPWpGaD
Decitabine—DNMT1—DNA methylation—H2AFX—liver cancer	0.00356	0.0184	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CSF2—liver cancer	0.00344	0.0178	CbGpPWpGaD
Decitabine—DNMT1—PRC2 methylates histones and DNA—H2AFX—liver cancer	0.00323	0.0167	CbGpPWpGaD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—H2AFX—liver cancer	0.00307	0.0159	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—ABL1—liver cancer	0.00296	0.0153	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1B—liver cancer	0.00285	0.0147	CbGpPWpGaD
Decitabine—DNMT1—liver—liver cancer	0.0028	0.0945	CbGeAlD
Decitabine—DNMT1—Regulation of retinoblastoma protein—MAPK14—liver cancer	0.00278	0.0144	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—MET—liver cancer	0.00274	0.0142	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—liver cancer	0.00272	0.0141	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1A—liver cancer	0.00263	0.0136	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—PCNA—liver cancer	0.00254	0.0131	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—PPARG—liver cancer	0.00249	0.0129	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—ABL1—liver cancer	0.00245	0.0127	CbGpPWpGaD
Decitabine—DNMT1—NoRC negatively regulates rRNA expression—H2AFX—liver cancer	0.00239	0.0124	CbGpPWpGaD
Decitabine—DNMT3A—RMTs methylate histone arginines—CCND1—liver cancer	0.00237	0.0122	CbGpPWpGaD
Decitabine—DNMT1—Negative epigenetic regulation of rRNA expression—H2AFX—liver cancer	0.00234	0.0121	CbGpPWpGaD
Decitabine—Arthralgia—Sorafenib—liver cancer	0.00222	0.00293	CcSEcCtD
Decitabine—Myalgia—Sorafenib—liver cancer	0.00222	0.00293	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0022	0.00291	CcSEcCtD
Decitabine—Pulmonary embolism—Epirubicin—liver cancer	0.0022	0.00291	CcSEcCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—liver cancer	0.00218	0.0113	CbGpPWpGaD
Decitabine—Hyperkalaemia—Epirubicin—liver cancer	0.00216	0.00286	CcSEcCtD
Decitabine—Blood bilirubin increased—Doxorubicin—liver cancer	0.00216	0.00284	CcSEcCtD
Decitabine—Bone pain—Doxorubicin—liver cancer	0.00213	0.00281	CcSEcCtD
Decitabine—Anaphylactic shock—Sorafenib—liver cancer	0.00213	0.00281	CcSEcCtD
Decitabine—Infection—Sorafenib—liver cancer	0.00211	0.00279	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—liver cancer	0.00211	0.0109	CbGpPWpGaD
Decitabine—Candida infection—Epirubicin—liver cancer	0.0021	0.00278	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—liver cancer	0.0021	0.0108	CbGpPWpGaD
Decitabine—Nervous system disorder—Sorafenib—liver cancer	0.00209	0.00275	CcSEcCtD
Decitabine—Thrombocytopenia—Sorafenib—liver cancer	0.00208	0.00275	CcSEcCtD
Decitabine—Blood urea increased—Epirubicin—liver cancer	0.00208	0.00274	CcSEcCtD
Decitabine—DNMT1—Epigenetic regulation of gene expression—H2AFX—liver cancer	0.00207	0.0107	CbGpPWpGaD
Decitabine—Skin disorder—Sorafenib—liver cancer	0.00207	0.00273	CcSEcCtD
Decitabine—Musculoskeletal pain—Doxorubicin—liver cancer	0.00206	0.00272	CcSEcCtD
Decitabine—Pulmonary embolism—Doxorubicin—liver cancer	0.00204	0.00269	CcSEcCtD
Decitabine—Anorexia—Sorafenib—liver cancer	0.00203	0.00267	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—RAF1—liver cancer	0.00203	0.0105	CbGpPWpGaD
Decitabine—Hyperkalaemia—Doxorubicin—liver cancer	0.002	0.00264	CcSEcCtD
Decitabine—Ecchymosis—Epirubicin—liver cancer	0.00199	0.00263	CcSEcCtD
Decitabine—Pulmonary oedema—Epirubicin—liver cancer	0.00196	0.00259	CcSEcCtD
Decitabine—Candida infection—Doxorubicin—liver cancer	0.00195	0.00257	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00194	0.00256	CcSEcCtD
Decitabine—DNMT3A—Chromatin modifying enzymes—H2AFX—liver cancer	0.00194	0.01	CbGpPWpGaD
Decitabine—DCK—liver—liver cancer	0.00194	0.0654	CbGeAlD
Decitabine—Blood urea increased—Doxorubicin—liver cancer	0.00192	0.00254	CcSEcCtD
Decitabine—Sepsis—Epirubicin—liver cancer	0.00191	0.00252	CcSEcCtD
Decitabine—Dyspnoea—Sorafenib—liver cancer	0.0019	0.0025	CcSEcCtD
Decitabine—Lymphadenopathy—Epirubicin—liver cancer	0.00187	0.00247	CcSEcCtD
Decitabine—Dyspepsia—Sorafenib—liver cancer	0.00187	0.00247	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN1B—liver cancer	0.00186	0.00959	CbGpPWpGaD
Decitabine—Decreased appetite—Sorafenib—liver cancer	0.00185	0.00244	CcSEcCtD
Decitabine—Ecchymosis—Doxorubicin—liver cancer	0.00184	0.00243	CcSEcCtD
Decitabine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00184	0.00243	CcSEcCtD
Decitabine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00184	0.00242	CcSEcCtD
Decitabine—Fatigue—Sorafenib—liver cancer	0.00183	0.00242	CcSEcCtD
Decitabine—Constipation—Sorafenib—liver cancer	0.00182	0.0024	CcSEcCtD
Decitabine—Pain—Sorafenib—liver cancer	0.00182	0.0024	CcSEcCtD
Decitabine—Pulmonary oedema—Doxorubicin—liver cancer	0.00181	0.00239	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CCND1—liver cancer	0.00177	0.00915	CbGpPWpGaD
Decitabine—Sepsis—Doxorubicin—liver cancer	0.00177	0.00233	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—JUN—liver cancer	0.00177	0.00913	CbGpPWpGaD
Decitabine—Cardiac failure congestive—Epirubicin—liver cancer	0.00176	0.00233	CcSEcCtD
Decitabine—Gastrointestinal pain—Sorafenib—liver cancer	0.00174	0.00229	CcSEcCtD
Decitabine—Lymphadenopathy—Doxorubicin—liver cancer	0.00173	0.00229	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN1A—liver cancer	0.00171	0.00885	CbGpPWpGaD
Decitabine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.0017	0.00224	CcSEcCtD
Decitabine—Urticaria—Sorafenib—liver cancer	0.00169	0.00223	CcSEcCtD
Decitabine—Body temperature increased—Sorafenib—liver cancer	0.00168	0.00222	CcSEcCtD
Decitabine—Abdominal pain—Sorafenib—liver cancer	0.00168	0.00222	CcSEcCtD
Decitabine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00165	0.00218	CcSEcCtD
Decitabine—Lethargy—Epirubicin—liver cancer	0.00163	0.00215	CcSEcCtD
Decitabine—Cardiac failure congestive—Doxorubicin—liver cancer	0.00163	0.00215	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—RAF1—liver cancer	0.00162	0.00839	CbGpPWpGaD
Decitabine—Hyponatraemia—Epirubicin—liver cancer	0.00161	0.00212	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—EXOSC2—liver cancer	0.0016	0.00827	CbGpPWpGaD
Decitabine—Pain in extremity—Epirubicin—liver cancer	0.0016	0.00211	CcSEcCtD
Decitabine—Hypersensitivity—Sorafenib—liver cancer	0.00157	0.00207	CcSEcCtD
Decitabine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00153	0.00202	CcSEcCtD
Decitabine—Asthenia—Sorafenib—liver cancer	0.00153	0.00201	CcSEcCtD
Decitabine—Lethargy—Doxorubicin—liver cancer	0.00151	0.00199	CcSEcCtD
Decitabine—Pruritus—Sorafenib—liver cancer	0.0015	0.00199	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1B—liver cancer	0.00149	0.00769	CbGpPWpGaD
Decitabine—Dehydration—Epirubicin—liver cancer	0.00149	0.00196	CcSEcCtD
Decitabine—Hyponatraemia—Doxorubicin—liver cancer	0.00149	0.00196	CcSEcCtD
Decitabine—Pain in extremity—Doxorubicin—liver cancer	0.00148	0.00195	CcSEcCtD
Decitabine—Liver function test abnormal—Epirubicin—liver cancer	0.00148	0.00195	CcSEcCtD
Decitabine—Dry skin—Epirubicin—liver cancer	0.00147	0.00193	CcSEcCtD
Decitabine—Abdominal pain upper—Epirubicin—liver cancer	0.00146	0.00193	CcSEcCtD
Decitabine—Hypokalaemia—Epirubicin—liver cancer	0.00146	0.00192	CcSEcCtD
Decitabine—Diarrhoea—Sorafenib—liver cancer	0.00146	0.00192	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00144	0.0019	CcSEcCtD
Decitabine—Nasopharyngitis—Epirubicin—liver cancer	0.00143	0.00189	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—liver cancer	0.00142	0.00734	CbGpPWpGaD
Decitabine—Muscular weakness—Epirubicin—liver cancer	0.00141	0.00186	CcSEcCtD
Decitabine—Dizziness—Sorafenib—liver cancer	0.00141	0.00186	CcSEcCtD
Decitabine—Abdominal distension—Epirubicin—liver cancer	0.00139	0.00184	CcSEcCtD
Decitabine—Dysphagia—Epirubicin—liver cancer	0.00138	0.00182	CcSEcCtD
Decitabine—Dehydration—Doxorubicin—liver cancer	0.00138	0.00182	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1A—liver cancer	0.00137	0.0071	CbGpPWpGaD
Decitabine—Liver function test abnormal—Doxorubicin—liver cancer	0.00137	0.0018	CcSEcCtD
Decitabine—Dry skin—Doxorubicin—liver cancer	0.00136	0.00179	CcSEcCtD
Decitabine—Vomiting—Sorafenib—liver cancer	0.00135	0.00178	CcSEcCtD
Decitabine—Abdominal pain upper—Doxorubicin—liver cancer	0.00135	0.00178	CcSEcCtD
Decitabine—Hypokalaemia—Doxorubicin—liver cancer	0.00135	0.00178	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—RAF1—liver cancer	0.00134	0.00695	CbGpPWpGaD
Decitabine—Rash—Sorafenib—liver cancer	0.00134	0.00177	CcSEcCtD
Decitabine—Dermatitis—Sorafenib—liver cancer	0.00134	0.00177	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00133	0.00176	CcSEcCtD
Decitabine—Headache—Sorafenib—liver cancer	0.00133	0.00176	CcSEcCtD
Decitabine—Bronchitis—Epirubicin—liver cancer	0.00133	0.00175	CcSEcCtD
Decitabine—Nasopharyngitis—Doxorubicin—liver cancer	0.00132	0.00175	CcSEcCtD
Decitabine—Pancytopenia—Epirubicin—liver cancer	0.00131	0.00173	CcSEcCtD
Decitabine—Muscular weakness—Doxorubicin—liver cancer	0.00131	0.00172	CcSEcCtD
Decitabine—Dysuria—Epirubicin—liver cancer	0.00129	0.00171	CcSEcCtD
Decitabine—Neutropenia—Epirubicin—liver cancer	0.00129	0.00171	CcSEcCtD
Decitabine—Abdominal distension—Doxorubicin—liver cancer	0.00129	0.0017	CcSEcCtD
Decitabine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00128	0.0017	CcSEcCtD
Decitabine—Dysphagia—Doxorubicin—liver cancer	0.00128	0.00169	CcSEcCtD
Decitabine—Pollakiuria—Epirubicin—liver cancer	0.00128	0.00168	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—NR1H4—liver cancer	0.00127	0.00658	CbGpPWpGaD
Decitabine—Nausea—Sorafenib—liver cancer	0.00126	0.00167	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—NR1I3—liver cancer	0.00125	0.00647	CbGpPWpGaD
Decitabine—Weight decreased—Epirubicin—liver cancer	0.00125	0.00165	CcSEcCtD
Decitabine—Hyperglycaemia—Epirubicin—liver cancer	0.00125	0.00165	CcSEcCtD
Decitabine—Pneumonia—Epirubicin—liver cancer	0.00124	0.00164	CcSEcCtD
Decitabine—Infestation NOS—Epirubicin—liver cancer	0.00123	0.00163	CcSEcCtD
Decitabine—Infestation—Epirubicin—liver cancer	0.00123	0.00163	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—liver cancer	0.00123	0.00637	CbGpPWpGaD
Decitabine—Bronchitis—Doxorubicin—liver cancer	0.00123	0.00162	CcSEcCtD
Decitabine—Pancytopenia—Doxorubicin—liver cancer	0.00121	0.0016	CcSEcCtD
Decitabine—Renal failure—Epirubicin—liver cancer	0.00121	0.0016	CcSEcCtD
Decitabine—Stomatitis—Epirubicin—liver cancer	0.0012	0.00159	CcSEcCtD
Decitabine—Urinary tract infection—Epirubicin—liver cancer	0.0012	0.00158	CcSEcCtD
Decitabine—Dysuria—Doxorubicin—liver cancer	0.0012	0.00158	CcSEcCtD
Decitabine—Neutropenia—Doxorubicin—liver cancer	0.0012	0.00158	CcSEcCtD
Decitabine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00119	0.00157	CcSEcCtD
Decitabine—Pollakiuria—Doxorubicin—liver cancer	0.00118	0.00156	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—liver cancer	0.00118	0.00607	CbGpPWpGaD
Decitabine—Hepatobiliary disease—Epirubicin—liver cancer	0.00117	0.00154	CcSEcCtD
Decitabine—Epistaxis—Epirubicin—liver cancer	0.00116	0.00153	CcSEcCtD
Decitabine—Weight decreased—Doxorubicin—liver cancer	0.00116	0.00153	CcSEcCtD
Decitabine—Sinusitis—Epirubicin—liver cancer	0.00116	0.00153	CcSEcCtD
Decitabine—Hyperglycaemia—Doxorubicin—liver cancer	0.00115	0.00152	CcSEcCtD
Decitabine—Pneumonia—Doxorubicin—liver cancer	0.00115	0.00151	CcSEcCtD
Decitabine—Infestation NOS—Doxorubicin—liver cancer	0.00114	0.0015	CcSEcCtD
Decitabine—Infestation—Doxorubicin—liver cancer	0.00114	0.0015	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—liver cancer	0.00114	0.00588	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—liver cancer	0.00114	0.00587	CbGpPWpGaD
Decitabine—Renal failure—Doxorubicin—liver cancer	0.00112	0.00148	CcSEcCtD
Decitabine—Haemoglobin—Epirubicin—liver cancer	0.00111	0.00147	CcSEcCtD
Decitabine—Stomatitis—Doxorubicin—liver cancer	0.00111	0.00147	CcSEcCtD
Decitabine—Urinary tract infection—Doxorubicin—liver cancer	0.00111	0.00146	CcSEcCtD
Decitabine—Haemorrhage—Epirubicin—liver cancer	0.00111	0.00146	CcSEcCtD
Decitabine—Hypoaesthesia—Epirubicin—liver cancer	0.0011	0.00145	CcSEcCtD
Decitabine—Pharyngitis—Epirubicin—liver cancer	0.0011	0.00145	CcSEcCtD
Decitabine—Urinary tract disorder—Epirubicin—liver cancer	0.00109	0.00144	CcSEcCtD
Decitabine—Oedema peripheral—Epirubicin—liver cancer	0.00109	0.00144	CcSEcCtD
Decitabine—Connective tissue disorder—Epirubicin—liver cancer	0.00109	0.00143	CcSEcCtD
Decitabine—Urethral disorder—Epirubicin—liver cancer	0.00108	0.00143	CcSEcCtD
Decitabine—DNMT1—Gene Expression—EXOSC2—liver cancer	0.00108	0.00559	CbGpPWpGaD
Decitabine—Hepatobiliary disease—Doxorubicin—liver cancer	0.00108	0.00142	CcSEcCtD
Decitabine—Epistaxis—Doxorubicin—liver cancer	0.00108	0.00142	CcSEcCtD
Decitabine—Sinusitis—Doxorubicin—liver cancer	0.00107	0.00141	CcSEcCtD
Decitabine—Eye disorder—Epirubicin—liver cancer	0.00103	0.00136	CcSEcCtD
Decitabine—Haemoglobin—Doxorubicin—liver cancer	0.00103	0.00136	CcSEcCtD
Decitabine—Cardiac disorder—Epirubicin—liver cancer	0.00103	0.00135	CcSEcCtD
Decitabine—Haemorrhage—Doxorubicin—liver cancer	0.00102	0.00135	CcSEcCtD
Decitabine—Hypoaesthesia—Doxorubicin—liver cancer	0.00102	0.00134	CcSEcCtD
Decitabine—Pharyngitis—Doxorubicin—liver cancer	0.00102	0.00134	CcSEcCtD
Decitabine—DNMT3A—Chromatin modifying enzymes—CCND1—liver cancer	0.00101	0.00523	CbGpPWpGaD
Decitabine—Urinary tract disorder—Doxorubicin—liver cancer	0.00101	0.00133	CcSEcCtD
Decitabine—Oedema peripheral—Doxorubicin—liver cancer	0.00101	0.00133	CcSEcCtD
Decitabine—Connective tissue disorder—Doxorubicin—liver cancer	0.00101	0.00133	CcSEcCtD
Decitabine—Angiopathy—Epirubicin—liver cancer	0.001	0.00132	CcSEcCtD
Decitabine—Urethral disorder—Doxorubicin—liver cancer	0.001	0.00132	CcSEcCtD
Decitabine—Immune system disorder—Epirubicin—liver cancer	0.000999	0.00132	CcSEcCtD
Decitabine—Mediastinal disorder—Epirubicin—liver cancer	0.000997	0.00132	CcSEcCtD
Decitabine—Chills—Epirubicin—liver cancer	0.000993	0.00131	CcSEcCtD
Decitabine—Alopecia—Epirubicin—liver cancer	0.000978	0.00129	CcSEcCtD
Decitabine—Mental disorder—Epirubicin—liver cancer	0.000969	0.00128	CcSEcCtD
Decitabine—Erythema—Epirubicin—liver cancer	0.000963	0.00127	CcSEcCtD
Decitabine—Malnutrition—Epirubicin—liver cancer	0.000963	0.00127	CcSEcCtD
Decitabine—Eye disorder—Doxorubicin—liver cancer	0.000957	0.00126	CcSEcCtD
Decitabine—Cardiac disorder—Doxorubicin—liver cancer	0.00095	0.00125	CcSEcCtD
Decitabine—DCK—Metabolism—UGDH—liver cancer	0.000948	0.0049	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—liver cancer	0.000943	0.00487	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000935	0.00483	CbGpPWpGaD
Decitabine—Back pain—Epirubicin—liver cancer	0.000932	0.00123	CcSEcCtD
Decitabine—Angiopathy—Doxorubicin—liver cancer	0.000929	0.00123	CcSEcCtD
Decitabine—Muscle spasms—Epirubicin—liver cancer	0.000926	0.00122	CcSEcCtD
Decitabine—Immune system disorder—Doxorubicin—liver cancer	0.000925	0.00122	CcSEcCtD
Decitabine—Mediastinal disorder—Doxorubicin—liver cancer	0.000923	0.00122	CcSEcCtD
Decitabine—Chills—Doxorubicin—liver cancer	0.000918	0.00121	CcSEcCtD
Decitabine—Vision blurred—Epirubicin—liver cancer	0.000908	0.0012	CcSEcCtD
Decitabine—Alopecia—Doxorubicin—liver cancer	0.000905	0.00119	CcSEcCtD
Decitabine—Mental disorder—Doxorubicin—liver cancer	0.000897	0.00118	CcSEcCtD
Decitabine—Ill-defined disorder—Epirubicin—liver cancer	0.000894	0.00118	CcSEcCtD
Decitabine—DCK—Metabolism—EPT1—liver cancer	0.000892	0.00461	CbGpPWpGaD
Decitabine—Erythema—Doxorubicin—liver cancer	0.000891	0.00118	CcSEcCtD
Decitabine—Malnutrition—Doxorubicin—liver cancer	0.000891	0.00118	CcSEcCtD
Decitabine—Anaemia—Epirubicin—liver cancer	0.00089	0.00117	CcSEcCtD
Decitabine—Malaise—Epirubicin—liver cancer	0.000868	0.00115	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—HNF4A—liver cancer	0.000868	0.00449	CbGpPWpGaD
Decitabine—Leukopenia—Epirubicin—liver cancer	0.000862	0.00114	CcSEcCtD
Decitabine—Back pain—Doxorubicin—liver cancer	0.000862	0.00114	CcSEcCtD
Decitabine—DNMT1—Gene Expression—NR1H4—liver cancer	0.000861	0.00445	CbGpPWpGaD
Decitabine—Muscle spasms—Doxorubicin—liver cancer	0.000857	0.00113	CcSEcCtD
Decitabine—DNMT1—Gene Expression—NR1I3—liver cancer	0.000846	0.00437	CbGpPWpGaD
Decitabine—DCK—Metabolism—TAT—liver cancer	0.000845	0.00437	CbGpPWpGaD
Decitabine—Cough—Epirubicin—liver cancer	0.00084	0.00111	CcSEcCtD
Decitabine—Vision blurred—Doxorubicin—liver cancer	0.00084	0.00111	CcSEcCtD
Decitabine—Hypertension—Epirubicin—liver cancer	0.000831	0.0011	CcSEcCtD
Decitabine—Ill-defined disorder—Doxorubicin—liver cancer	0.000827	0.00109	CcSEcCtD
Decitabine—Anaemia—Doxorubicin—liver cancer	0.000824	0.00109	CcSEcCtD
Decitabine—Arthralgia—Epirubicin—liver cancer	0.00082	0.00108	CcSEcCtD
Decitabine—Chest pain—Epirubicin—liver cancer	0.00082	0.00108	CcSEcCtD
Decitabine—Myalgia—Epirubicin—liver cancer	0.00082	0.00108	CcSEcCtD
Decitabine—Anxiety—Epirubicin—liver cancer	0.000817	0.00108	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000814	0.00107	CcSEcCtD
Decitabine—Discomfort—Epirubicin—liver cancer	0.00081	0.00107	CcSEcCtD
Decitabine—Malaise—Doxorubicin—liver cancer	0.000804	0.00106	CcSEcCtD
Decitabine—Leukopenia—Doxorubicin—liver cancer	0.000798	0.00105	CcSEcCtD
Decitabine—Confusional state—Epirubicin—liver cancer	0.000792	0.00105	CcSEcCtD
Decitabine—Oedema—Epirubicin—liver cancer	0.000786	0.00104	CcSEcCtD
Decitabine—Anaphylactic shock—Epirubicin—liver cancer	0.000786	0.00104	CcSEcCtD
Decitabine—Infection—Epirubicin—liver cancer	0.000781	0.00103	CcSEcCtD
Decitabine—Cough—Doxorubicin—liver cancer	0.000778	0.00103	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000774	0.004	CbGpPWpGaD
Decitabine—Nervous system disorder—Epirubicin—liver cancer	0.000771	0.00102	CcSEcCtD
Decitabine—Thrombocytopenia—Epirubicin—liver cancer	0.00077	0.00102	CcSEcCtD
Decitabine—Hypertension—Doxorubicin—liver cancer	0.000769	0.00102	CcSEcCtD
Decitabine—Tachycardia—Epirubicin—liver cancer	0.000767	0.00101	CcSEcCtD
Decitabine—Skin disorder—Epirubicin—liver cancer	0.000763	0.00101	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—PSMA4—liver cancer	0.000759	0.00392	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—PSMD10—liver cancer	0.000759	0.00392	CbGpPWpGaD
Decitabine—Arthralgia—Doxorubicin—liver cancer	0.000759	0.001	CcSEcCtD
Decitabine—Chest pain—Doxorubicin—liver cancer	0.000759	0.001	CcSEcCtD
Decitabine—Myalgia—Doxorubicin—liver cancer	0.000759	0.001	CcSEcCtD
Decitabine—Anxiety—Doxorubicin—liver cancer	0.000756	0.000998	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000753	0.000994	CcSEcCtD
Decitabine—Discomfort—Doxorubicin—liver cancer	0.00075	0.000989	CcSEcCtD
Decitabine—Anorexia—Epirubicin—liver cancer	0.000749	0.000989	CcSEcCtD
Decitabine—Hypotension—Epirubicin—liver cancer	0.000734	0.000969	CcSEcCtD
Decitabine—Confusional state—Doxorubicin—liver cancer	0.000733	0.000968	CcSEcCtD
Decitabine—Anaphylactic shock—Doxorubicin—liver cancer	0.000727	0.00096	CcSEcCtD
Decitabine—Oedema—Doxorubicin—liver cancer	0.000727	0.00096	CcSEcCtD
Decitabine—Infection—Doxorubicin—liver cancer	0.000722	0.000953	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000716	0.000945	CcSEcCtD
Decitabine—Nervous system disorder—Doxorubicin—liver cancer	0.000713	0.000941	CcSEcCtD
Decitabine—Thrombocytopenia—Doxorubicin—liver cancer	0.000712	0.00094	CcSEcCtD
Decitabine—Insomnia—Epirubicin—liver cancer	0.000711	0.000938	CcSEcCtD
Decitabine—Tachycardia—Doxorubicin—liver cancer	0.00071	0.000937	CcSEcCtD
Decitabine—Skin disorder—Doxorubicin—liver cancer	0.000706	0.000932	CcSEcCtD
Decitabine—Dyspnoea—Epirubicin—liver cancer	0.000701	0.000925	CcSEcCtD
Decitabine—Anorexia—Doxorubicin—liver cancer	0.000693	0.000915	CcSEcCtD
Decitabine—Dyspepsia—Epirubicin—liver cancer	0.000692	0.000913	CcSEcCtD
Decitabine—Decreased appetite—Epirubicin—liver cancer	0.000683	0.000902	CcSEcCtD
Decitabine—Hypotension—Doxorubicin—liver cancer	0.00068	0.000897	CcSEcCtD
Decitabine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000679	0.000895	CcSEcCtD
Decitabine—Fatigue—Epirubicin—liver cancer	0.000678	0.000894	CcSEcCtD
Decitabine—Pain—Epirubicin—liver cancer	0.000672	0.000887	CcSEcCtD
Decitabine—Constipation—Epirubicin—liver cancer	0.000672	0.000887	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000663	0.000874	CcSEcCtD
Decitabine—Insomnia—Doxorubicin—liver cancer	0.000658	0.000868	CcSEcCtD
Decitabine—Dyspnoea—Doxorubicin—liver cancer	0.000648	0.000856	CcSEcCtD
Decitabine—Feeling abnormal—Epirubicin—liver cancer	0.000648	0.000855	CcSEcCtD
Decitabine—Gastrointestinal pain—Epirubicin—liver cancer	0.000643	0.000848	CcSEcCtD
Decitabine—Dyspepsia—Doxorubicin—liver cancer	0.00064	0.000845	CcSEcCtD
Decitabine—Decreased appetite—Doxorubicin—liver cancer	0.000632	0.000834	CcSEcCtD
Decitabine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000628	0.000828	CcSEcCtD
Decitabine—Fatigue—Doxorubicin—liver cancer	0.000627	0.000827	CcSEcCtD
Decitabine—Urticaria—Epirubicin—liver cancer	0.000624	0.000824	CcSEcCtD
Decitabine—Pain—Doxorubicin—liver cancer	0.000622	0.000821	CcSEcCtD
Decitabine—Constipation—Doxorubicin—liver cancer	0.000622	0.000821	CcSEcCtD
Decitabine—Body temperature increased—Epirubicin—liver cancer	0.000621	0.00082	CcSEcCtD
Decitabine—Abdominal pain—Epirubicin—liver cancer	0.000621	0.00082	CcSEcCtD
Decitabine—Feeling abnormal—Doxorubicin—liver cancer	0.000599	0.000791	CcSEcCtD
Decitabine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000595	0.000785	CcSEcCtD
Decitabine—DNMT1—Gene Expression—HNF4A—liver cancer	0.000587	0.00303	CbGpPWpGaD
Decitabine—Hypersensitivity—Epirubicin—liver cancer	0.000579	0.000764	CcSEcCtD
Decitabine—Urticaria—Doxorubicin—liver cancer	0.000578	0.000762	CcSEcCtD
Decitabine—Abdominal pain—Doxorubicin—liver cancer	0.000575	0.000759	CcSEcCtD
Decitabine—Body temperature increased—Doxorubicin—liver cancer	0.000575	0.000759	CcSEcCtD
Decitabine—DCK—Metabolism—CPT1B—liver cancer	0.000575	0.00297	CbGpPWpGaD
Decitabine—DCK—Metabolism—GLUL—liver cancer	0.000575	0.00297	CbGpPWpGaD
Decitabine—Asthenia—Epirubicin—liver cancer	0.000564	0.000744	CcSEcCtD
Decitabine—Pruritus—Epirubicin—liver cancer	0.000556	0.000734	CcSEcCtD
Decitabine—DCK—Metabolism—NR1H4—liver cancer	0.000554	0.00286	CbGpPWpGaD
Decitabine—DCK—Metabolism—GSTA3—liver cancer	0.000545	0.00281	CbGpPWpGaD
Decitabine—Diarrhoea—Epirubicin—liver cancer	0.000538	0.00071	CcSEcCtD
Decitabine—Hypersensitivity—Doxorubicin—liver cancer	0.000536	0.000707	CcSEcCtD
Decitabine—Asthenia—Doxorubicin—liver cancer	0.000522	0.000689	CcSEcCtD
Decitabine—Dizziness—Epirubicin—liver cancer	0.00052	0.000686	CcSEcCtD
Decitabine—Pruritus—Doxorubicin—liver cancer	0.000515	0.000679	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—H2AFX—liver cancer	0.000513	0.00265	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PSMA4—liver cancer	0.000513	0.00265	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PSMD10—liver cancer	0.000513	0.00265	CbGpPWpGaD
Decitabine—Vomiting—Epirubicin—liver cancer	0.0005	0.000659	CcSEcCtD
Decitabine—DCK—Metabolism—GSTA4—liver cancer	0.000498	0.00257	CbGpPWpGaD
Decitabine—Diarrhoea—Doxorubicin—liver cancer	0.000498	0.000657	CcSEcCtD
Decitabine—Rash—Epirubicin—liver cancer	0.000496	0.000654	CcSEcCtD
Decitabine—Dermatitis—Epirubicin—liver cancer	0.000495	0.000653	CcSEcCtD
Decitabine—Headache—Epirubicin—liver cancer	0.000492	0.00065	CcSEcCtD
Decitabine—DCK—Metabolism—GSTA2—liver cancer	0.000485	0.00251	CbGpPWpGaD
Decitabine—Dizziness—Doxorubicin—liver cancer	0.000481	0.000635	CcSEcCtD
Decitabine—DCK—Metabolism—GSTA1—liver cancer	0.000468	0.00242	CbGpPWpGaD
Decitabine—Nausea—Epirubicin—liver cancer	0.000467	0.000616	CcSEcCtD
Decitabine—DCK—Metabolism—NAT2—liver cancer	0.000463	0.00239	CbGpPWpGaD
Decitabine—Vomiting—Doxorubicin—liver cancer	0.000462	0.00061	CcSEcCtD
Decitabine—Rash—Doxorubicin—liver cancer	0.000459	0.000605	CcSEcCtD
Decitabine—Dermatitis—Doxorubicin—liver cancer	0.000458	0.000604	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—PPARA—liver cancer	0.000456	0.00236	CbGpPWpGaD
Decitabine—Headache—Doxorubicin—liver cancer	0.000456	0.000601	CcSEcCtD
Decitabine—DCK—Metabolism—ALDOB—liver cancer	0.000444	0.00229	CbGpPWpGaD
Decitabine—Nausea—Doxorubicin—liver cancer	0.000432	0.00057	CcSEcCtD
Decitabine—DCK—Metabolism—CRABP1—liver cancer	0.000424	0.00219	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—MAPK14—liver cancer	0.000421	0.00218	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—ESR1—liver cancer	0.000413	0.00214	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—PPARG—liver cancer	0.000377	0.00195	CbGpPWpGaD
Decitabine—DCK—Metabolism—HPGDS—liver cancer	0.00037	0.00191	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—H2AFX—liver cancer	0.000346	0.00179	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—SERPINE1—liver cancer	0.00034	0.00175	CbGpPWpGaD
Decitabine—DCK—Metabolism—PSMD10—liver cancer	0.00033	0.0017	CbGpPWpGaD
Decitabine—DCK—Metabolism—PSMA4—liver cancer	0.00033	0.0017	CbGpPWpGaD
Decitabine—DCK—Metabolism—GOT2—liver cancer	0.000321	0.00166	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PPARA—liver cancer	0.000308	0.00159	CbGpPWpGaD
Decitabine—DCK—Metabolism—CYP2E1—liver cancer	0.000302	0.00156	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—MAPK14—liver cancer	0.000285	0.00147	CbGpPWpGaD
Decitabine—DCK—Metabolism—CYCS—liver cancer	0.000282	0.00146	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—ESR1—liver cancer	0.000279	0.00144	CbGpPWpGaD
Decitabine—DCK—Metabolism—GOT1—liver cancer	0.000277	0.00143	CbGpPWpGaD
Decitabine—DCK—Metabolism—GGT1—liver cancer	0.000277	0.00143	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PPARG—liver cancer	0.000255	0.00132	CbGpPWpGaD
Decitabine—DCK—Metabolism—GSTP1—liver cancer	0.000249	0.00129	CbGpPWpGaD
Decitabine—DCK—Metabolism—HMOX1—liver cancer	0.000245	0.00127	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—SERPINE1—liver cancer	0.000229	0.00119	CbGpPWpGaD
Decitabine—DCK—Metabolism—GSTM1—liver cancer	0.000229	0.00118	CbGpPWpGaD
Decitabine—DCK—Metabolism—CYP1A1—liver cancer	0.000217	0.00112	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—MYC—liver cancer	0.000215	0.00111	CbGpPWpGaD
Decitabine—DCK—Metabolism—MTHFR—liver cancer	0.000202	0.00104	CbGpPWpGaD
Decitabine—DCK—Metabolism—PPARA—liver cancer	0.000198	0.00102	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CG—liver cancer	0.00017	0.000878	CbGpPWpGaD
Decitabine—DCK—Metabolism—PPARG—liver cancer	0.000164	0.000847	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CD—liver cancer	0.000149	0.000771	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—AKT1—liver cancer	0.000149	0.00077	CbGpPWpGaD
Decitabine—DCK—Metabolism—ALB—liver cancer	0.000147	0.000762	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—MYC—liver cancer	0.000145	0.00075	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CB—liver cancer	0.00013	0.000672	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—AKT1—liver cancer	0.000101	0.00052	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CA—liver cancer	7.93e-05	0.00041	CbGpPWpGaD
Decitabine—DCK—Metabolism—AKT1—liver cancer	6.48e-05	0.000335	CbGpPWpGaD
